Aurobindo Pharma gains 10% in three days on USFDA approval

Posted By:
Subscribe to GoodReturns

 Aurobindo Pharma gains 10% in three days on USFDA approval
Aurobindo Pharma: Quotes, News
BSE 722.25BSE Quote0.55 (0.08%)
NSE 720.50NSE Quote2.15 (0.30%)
Shares of Aurobindo Pharma jumped once again on Monday by 2%, gaining almost 10% in three trading sessions. The shares were last trading at Rs 130.75 on the Bombay Stock Exchange.

Aurobindo Pharma has been rising ever since the company secured final approval from the USFDA to manufacture & market Amlodipine Besylate and Benazepril Hydrochloride Capsules.

The company is an integrated pharma company, which features among the top 10 companies in India in terms of consolidated revenues.
Aurobindo exports to over 125 countries across the globe with more than 70% of its revenues derived out of international operations.

Read more about: aurobindo pharma
Story first published: Monday, September 10, 2012, 12:00 [IST]
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Thousands of Goodreturn readers receive our evening newsletter.
Have you subscribed?